BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22542153)

  • 1. Prevention of damage induced by aspirin in the GI tract.
    Scheiman JM
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):153-62. PubMed ID: 22542153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.
    Zhu LL; Xu LC; Chen Y; Zhou Q; Zeng S
    World J Gastroenterol; 2012 Jun; 18(24):3167-72. PubMed ID: 22791953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Niro V; Longo MG; D'Ambrosio LP; Andriulli A; Di Mario F
    Aging Clin Exp Res; 2003 Dec; 15(6):494-9. PubMed ID: 14959953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
    Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
    Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPIs Prevent Aspirin-Induced Gastrointestinal Bleeding Better than H2RAs. A Systematic Review and Meta-analysis.
    Szabó IL; Mátics R; Hegyi P; Garami A; Illés A; Sarlós P; Bajor J; Szűcs A; Mosztbacher D; Márta K; Szemes K; Csekő K; Kővári B; Rumbus Z; Vincze Á
    J Gastrointestin Liver Dis; 2017 Dec; 26(4):395-402. PubMed ID: 29253055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
    Morini S; Zullo A
    G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
    [No Abstract]   [Full Text] [Related]  

  • 9. Summaries for patients. Benefits and risks of continuing aspirin in patients with peptic ulcer bleeding.
    Ann Intern Med; 2010 Jan; 152(1):I-20. PubMed ID: 19949137
    [No Abstract]   [Full Text] [Related]  

  • 10. PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis.
    Mo C; Sun G; Wang YZ; Lu ML; Yang YS
    PLoS One; 2015; 10(7):e0131558. PubMed ID: 26147767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.
    Sung JJ; Lau JY; Ching JY; Wu JC; Lee YT; Chiu PW; Leung VK; Wong VW; Chan FK
    Ann Intern Med; 2010 Jan; 152(1):1-9. PubMed ID: 19949136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].
    Nardulli G; Lanas A
    Gastroenterol Hepatol; 2009 Jan; 32(1):36-43. PubMed ID: 19174098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice.
    Lanas A
    Expert Opin Drug Saf; 2011 Jan; 10(1):45-54. PubMed ID: 20645883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries.
    Mo C; Sun G; Lu ML; Zhang L; Wang YZ; Sun X; Yang YS
    World J Gastroenterol; 2015 May; 21(17):5382-92. PubMed ID: 25954113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.
    Lanas A; Scheiman J
    Curr Med Res Opin; 2007 Jan; 23(1):163-73. PubMed ID: 17257477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits.
    Lué A; Lanas A
    World J Gastroenterol; 2016 Dec; 22(48):10477-10481. PubMed ID: 28082800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist.
    Johnson DA
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S15-22. PubMed ID: 17710072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is NSAIDs-related gastrointestinal damage preventable?
    Gargallo CJ; Lanas A
    J Dig Dis; 2013 Feb; 14(2):55-61. PubMed ID: 23216831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease.
    Miyake K; Akimoto T; Hanada Y; Nagoya H; Kodaka Y; Ueki N; Kusunoki M; Kawagoe T; Futagami S; Takahashi Y; Takano H; Sakamoto C
    Dig Liver Dis; 2015 Sep; 47(9):757-62. PubMed ID: 26105589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus.
    Peura DA; Wilcox CM
    Postgrad Med; 2014 Jan; 126(1):87-96. PubMed ID: 24393755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.